Clinical Trial Update: MW151-101: First-in-human Study of MW151 [Phase 1]

View source ↗

Summary

First-in-human Phase 1 study of MW151 for Drug Toxicity completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug Toxicity

Drugs mentioned

• MW151

Snippet

Sponsor: Linda Van Eldik | Conditions: Drug Toxicity | Phase 1 | Status: COMPLETED | Results posted: 2022-12-30